Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Assets (2021 - 2025)

Rxo (RXO) has disclosed Assets for 5 consecutive years, with $3.2 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets fell 5.63% year-over-year to $3.2 billion, compared with a TTM value of $3.2 billion through Sep 2025, down 5.63%, and an annual FY2024 reading of $3.4 billion, up 87.07% over the prior year.
  • Assets was $3.2 billion for Q3 2025 at Rxo, roughly flat from $3.2 billion in the prior quarter.
  • Across five years, Assets topped out at $3.4 billion in Q4 2024 and bottomed at $1.8 billion in Q1 2024.
  • Average Assets over 5 years is $2.4 billion, with a median of $2.0 billion recorded in 2021.
  • The sharpest move saw Assets dropped 13.01% in 2023, then skyrocketed 87.07% in 2024.
  • Year by year, Assets stood at $2.1 billion in 2021, then fell by 1.79% to $2.0 billion in 2022, then fell by 10.14% to $1.8 billion in 2023, then surged by 87.07% to $3.4 billion in 2024, then dropped by 6.24% to $3.2 billion in 2025.
  • Business Quant data shows Assets for RXO at $3.2 billion in Q3 2025, $3.2 billion in Q2 2025, and $3.3 billion in Q1 2025.